RCM
VERA icon

RA Capital Management’s Vera Therapeutics VERA Stock Holding History

RA Capital Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,578,820
Closed -$33.6M – 84
2022
Q3 		$33.6M Hold
1,578,820
– – 0.72% 42
2022
Q2 		$21.5M Sell
1,578,820
-387,264
-20% -$6.76M 0.57% 43
2022
Q1 		$46.2M Buy
+1,966,084
New +$42.3M 1.01% 31

Other funds holding VERA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

RA Capital Management's VERA Position: Q4 2022 in Review

RA Capital Management sold out of Vera Therapeutics (VERA) in Q4 2022, closing a stake of 1,578,820 shares — an estimated $33.6M sold.

RA Capital Management first reported a position in VERA in Q1 2022 and held it in 3 quarters. The position peaked at $46.2M in Q1 2022. 59 funds tracked by Wall St. Rank hold VERA as of Q4 2022.

  • RA Capital Management reported no remaining Vera Therapeutics position as of Q4 2022 after selling out during the quarter.
  • RA Capital Management sold 1,578,820 Vera Therapeutics shares in Q4 2022, an estimated $33.6M.
  • RA Capital Management first reported a position in Vera Therapeutics in Q1 2022 and held it in 3 quarters.
  • RA Capital Management's Vera Therapeutics position peaked at $46.2M in Q1 2022.
  • 59 funds tracked by Wall St. Rank held Vera Therapeutics as of Q4 2022.

Based on RA Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.